CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $793 | -40.8% | 28,830 | -27.0% | 0.04% | -36.2% |
Q2 2023 | $1,340 | +57.6% | 39,480 | +67.0% | 0.06% | +45.0% |
Q1 2023 | $850 | +129.7% | 23,636 | +185.0% | 0.04% | +100.0% |
Q4 2022 | $370 | -99.9% | 8,293 | -64.0% | 0.02% | -48.7% |
Q3 2022 | $647,000 | +27.4% | 23,033 | +22.2% | 0.04% | +2.6% |
Q2 2022 | $508,000 | +6.7% | 18,845 | +34.8% | 0.04% | +22.6% |
Q1 2022 | $476,000 | +71.2% | 13,985 | +94.6% | 0.03% | -11.4% |
Q4 2021 | $278,000 | -36.8% | 7,185 | -11.9% | 0.04% | -40.7% |
Q3 2021 | $440,000 | +129.2% | 8,155 | -25.7% | 0.06% | +7.3% |
Q4 2020 | $192,000 | -71.3% | 10,980 | -75.6% | 0.06% | -74.1% |
Q3 2020 | $668,000 | – | 45,070 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|